Skip to content

Clinical study of measuring carotid artery blood flow index by ultrasound to evaluate volume change in patients under general anesthesia

Clinical study of measuring carotid artery blood flow index by ultrasound to evaluate volume change in patients under general anesthesia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057505
Enrollment
Unknown
Registered
2022-03-14
Start date
2022-02-28
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension after induction of anesthesia

Interventions

Crystal group:Compound sodium chloride injection 6ml/kg was given 10min after endotracheal intubation and was rapidly injected intravenously within 15min
Colloid group:10min after endotracheal intubation was established, succinyl gelatin injection 6ml/kg was administered intravenously within 15min
Control group:After entering the room, an intravenous channel was established and 10ml/kg/h sodium lactate Ringer Solution was administered intravenously

Sponsors

Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are scheduled to undergo surgery under endotracheal intubation and general anesthesia; 2. ASA grade I - II; 3. Aged between 18 and 65; 4. Body mass index (BMI) 15-30kg /m^2; 5. No mental illness or cognitive impairment.

Exclusion criteria

Exclusion criteria: 1. Those who refuse ultrasonic monitoring and examination; 2. Patients with difficulty in airway or endotracheal intubation; 3. Patients who need to adopt protective lung ventilation strategy; Carotid artery anatomic malformation, atherosclerosis, stenosis, thrombosis or cervical surgery; 4. Patients with other severe peripheral vascular diseases or intracranial hypertension; 5. Preoperative uncontrolled hypertension; Recent use of hypertensive drugs; 6. Severe organ dysfunction of liver and kidney (e.g., blood creatinine and liver enzyme > 2 times the normal clinical limit); 7. Patients with cardiac insufficiency (EF < 45%), pulmonary hypertension or above moderate valvular disease; 8. Patients with cardiac pacemaker implantation and atrial fibrillation and other arrhythmias; 9. Severe anemia; 10. There are known studies involving drug or colloid allergy; 11. Emergency operation patients.

Design outcomes

Primary

MeasureTime frame
Carotid artery corrected ejection time;Common carotid artery peak velocity variation;Average peak flow velocity of common carotid artery;

Countries

China

Contacts

Public ContactLi Guocai

Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine (Futian)

guocailee@126.com+86 15818749090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026